Klcm Advisors, Inc. Northwest Biotherapeutics Inc Transaction History
Klcm Advisors, Inc.
- $840 Million
- Q4 2024
A detailed history of Klcm Advisors, Inc. transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Klcm Advisors, Inc. holds 10,000 shares of NWBO stock, worth $2,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$2,600
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
746KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC489KShares$127,0150.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$17,0490.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,6390.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$9,1000.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$6,1620.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $270M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...